Vincent Caggiano

4.9k total citations · 1 hit paper
55 papers, 3.8k citations indexed

About

Vincent Caggiano is a scholar working on Oncology, Cancer Research and Hematology. According to data from OpenAlex, Vincent Caggiano has authored 55 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 25 papers in Cancer Research and 13 papers in Hematology. Recurrent topics in Vincent Caggiano's work include Breast Cancer Treatment Studies (24 papers), Global Cancer Incidence and Screening (12 papers) and Breast Lesions and Carcinomas (8 papers). Vincent Caggiano is often cited by papers focused on Breast Cancer Treatment Studies (24 papers), Global Cancer Incidence and Screening (12 papers) and Breast Lesions and Carcinomas (8 papers). Vincent Caggiano collaborates with scholars based in United States and South Africa. Vincent Caggiano's co-authors include Carol Parise, Katrina Bauer, Monica Brown, Rosemary D. Cress, Walter T. Linde‐Zwirble, Richard V. Weiss, Alex Tsodikov, Patricia McGrath, Malcolm R. MacKenzie and Rafael Bornstein and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Vincent Caggiano

55 papers receiving 3.6k citations

Hit Papers

Descriptive analysis of estrogen receptor (ER)‐negative, ... 2007 2026 2013 2019 2007 500 1000 1.5k

Peers

Vincent Caggiano
Mark L. Graham United States
M. Bontenbal Netherlands
D C Tormey United States
M. Namer France
Daniel Rea United Kingdom
David L. Ahmann United States
Kapil Dhingra United States
A. Costa Italy
Mark L. Graham United States
Vincent Caggiano
Citations per year, relative to Vincent Caggiano Vincent Caggiano (= 1×) peers Mark L. Graham

Countries citing papers authored by Vincent Caggiano

Since Specialization
Citations

This map shows the geographic impact of Vincent Caggiano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Caggiano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Caggiano more than expected).

Fields of papers citing papers by Vincent Caggiano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Caggiano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Caggiano. The network helps show where Vincent Caggiano may publish in the future.

Co-authorship network of co-authors of Vincent Caggiano

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Caggiano. A scholar is included among the top collaborators of Vincent Caggiano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Caggiano. Vincent Caggiano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parise, Carol & Vincent Caggiano. (2023). The association of race/ethnicity in male breast cancer survival within similar comorbidity cohorts. Cancer. 129(5). 750–763. 1 indexed citations
2.
Parise, Carol & Vincent Caggiano. (2019). Differences in clinicopatholgic characteristics and risk of mortality between the triple positive and ER+/PR+/HER2− breast cancer subtypes. Cancer Causes & Control. 30(5). 417–424. 5 indexed citations
3.
Parise, Carol & Vincent Caggiano. (2018). The influence of marital status and race/ethnicity on risk of mortality for triple negative breast cancer. PLoS ONE. 13(4). e0196134–e0196134. 28 indexed citations
4.
Parise, Carol & Vincent Caggiano. (2017). Risk factors associated with the triple-negative breast cancer subtype within four race/ethnicities. Breast Cancer Research and Treatment. 163(1). 151–158. 20 indexed citations
5.
Parise, Carol & Vincent Caggiano. (2017). Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors. Breast Cancer Research and Treatment. 165(3). 743–750. 42 indexed citations
6.
Parise, Carol & Vincent Caggiano. (2016). Regional Variation in Disparities in Breast Cancer Specific Mortality Due to Race/Ethnicity, Socioeconomic Status, and Urbanization. Journal of Racial and Ethnic Health Disparities. 4(4). 706–717. 21 indexed citations
7.
Parise, Carol, Katrina Bauer, & Vincent Caggiano. (2011). Disparities in receipt of adjuvant radiation therapy after breast‐conserving surgery among the cancer‐reporting regions of California. Cancer. 118(9). 2516–2524. 33 indexed citations
8.
Bauer, Katrina, Carol Parise, & Vincent Caggiano. (2010). Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer. BMC Cancer. 10(1). 228–228. 67 indexed citations
10.
Parise, Carol, Katrina Bauer, & Vincent Caggiano. (2009). Variation in breast cancer subtypes with age and race/ethnicity. Critical Reviews in Oncology/Hematology. 76(1). 44–52. 88 indexed citations
11.
Brown, Monica, Alex Tsodikov, Katrina Bauer, Carol Parise, & Vincent Caggiano. (2008). The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor‐negative, invasive breast cancer: The California Cancer Registry, 1999–2004. Cancer. 112(4). 737–747. 145 indexed citations
12.
Bauer, Katrina, Monica Brown, Rosemary D. Cress, Carol Parise, & Vincent Caggiano. (2007). Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype. Cancer. 109(9). 1721–1728. 1645 indexed citations breakdown →
13.
Caggiano, Vincent, et al.. (2005). Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy. Cancer. 103(9). 1916–1924. 268 indexed citations
15.
McGrath, Patricia, et al.. (1998). Alternative Care Patient Choices for Adjunct Therapies Within a Cancer Center. Cancer Practice. 6(3). 176–181. 54 indexed citations
16.
Paglieroni, Teresa, Vincent Caggiano, & Malcolm R. MacKenzie. (1992). Abnormalities in immune regulation precede the development of multiple myeloma. American Journal of Hematology. 40(1). 51–55. 6 indexed citations
17.
Paglieroni, Teresa, et al.. (1992). Association of Bone Marrow Growth Pattern, Coexpression of CD14, and B‐Cell CD5 Antigen Density in 45 B‐Chronic Lymphocytic Leukemia (B‐CLL) Patients. Annals of the New York Academy of Sciences. 651(1). 484–485. 2 indexed citations
18.
MacKenzie, Malcolm R., Teresa Paglieroni, & Vincent Caggiano. (1991). CD5 positive immunoregulatory B cells in spleen populations from multiple myeloma patients. American Journal of Hematology. 37(3). 163–166. 9 indexed citations
19.
Gandara, David R., Edith A. Perez, Vincent Caggiano, et al.. (1990). High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group. Cancer Chemotherapy and Pharmacology. 27(3). 243–247. 12 indexed citations
20.
Paglieroni, Teresa, Vincent Caggiano, & Malcolm R. MacKenzie. (1988). CD5 positive immunoregulatory B cell subsets. American Journal of Hematology. 28(4). 276–278. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026